ATHA

Athira Pharma Inc

ATHA.US athira.com + Research + Basket
CIK 0001620463
Employees 26
Phone 425 620 8501
Fiscal year end December
IPO Sep 18, 2020
Address 18706 North Creek Parkway, Bothell, WA, United States, 98011
Price N/A
USD · NASDAQ
52-week range
3.71
8.36
Market Cap
26.62M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
6.79
Div. Yield
N/A
% Institutions
85.52%
% Insiders
13.37%

1 Year

+140.9%

3 Year

-72.5%

10 Year

-95.5%
Description

Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. Athira Pharma, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.

Actions

Add an action for ATHA.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Mark J. Litton M.B.A., Ph.D. President, CEO & Director 1968
Dr. Kevin Church Ph.D. Chief Scientific Officer 1985
Mr. Mark F. Worthington J.D. General Counsel, Chief Compliance Officer & Corporate Secretary 1966
Mr. Robert Renninger Chief Financial Officer 1984
Ms. Julie Rathbun Head of Investor Relations NA
Dr. Javier San Martin M.D. Chief Medical Officer 1965

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Jan 02, 2026 Mark James Litton N/A Sale 2.59K $6.88 $17.79K SEC
Jan 02, 2026 Mark Worthington N/A Sale 876.00 $6.88 $6.03K SEC
Jan 02, 2026 Martin Javier San N/A Sale 1.64K $6.88 $11.31K SEC
Jan 02, 2026 Robert Renninger N/A Sale 297.00 $6.88 $2.04K SEC
Jul 01, 2025 Mark James Litton N/A Sale 2.51K $2.90 $7.28K SEC
Jul 01, 2025 Mark Worthington N/A Sale 852.00 $2.90 $2.47K SEC
Jul 01, 2025 Martin Javier San N/A Sale 1.08K $2.90 $3.14K SEC
Jul 01, 2025 Robert Renninger N/A Sale 289.00 $2.90 $838.10 SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Perceptive Advisors LLC 540.30K Sep 30, 2025 5.75% $0.06 0.00%
COMMODORE CAPITAL LP 464.40K Dec 31, 2025 4.94% $0.23 0.00%
TCG Crossover Management, LLC 464.40K Dec 31, 2025 4.94% $0.11 0.00%
NEA Management Company, LLC 464.40K Dec 31, 2025 4.94% $0.18 0.00%
Kalehua Capital Management LLC 393.70K Dec 31, 2025 4.19% $2.95 0.00%
ADAR1 Capital Management LLC 393.70K Dec 31, 2025 4.19% $0.21 0.00%
Spruce Street Capital LP 393.70K Dec 31, 2025 4.19% $0.98 0.00%
Millennium Management LLC 324.45K Dec 31, 2025 3.45% $0.00 0.00%
Vanguard Group Inc 153.79K Dec 31, 2025 1.64% $0.00 0.00%
Propel Bio Management LLC 149.28K Dec 31, 2025 1.59% $0.96 0.00%
Simplify Asset Management Inc. 149.28K Dec 31, 2025 1.59% $0.02 0.00%
Seven Fleet Capital Management LP 127.95K Dec 31, 2025 1.36% $0.66 0.00%
Renaissance Technologies Corp 75.15K Dec 31, 2025 0.80% $0.00 44.73%
Pathstone Holdings LLC 38.61K Dec 31, 2025 0.41% $0.00 0.00%
BlackRock Inc 37.64K Sep 30, 2025 0.40% $0.00 -0.01%
Bank of America Corp 32.61K Sep 30, 2025 0.35% $0.00 -21.64%
Geode Capital Management, LLC 30.94K Dec 31, 2025 0.33% $0.00 1.15%
Laird Norton Tyee Trust Co 21.82K Dec 31, 2025 0.23% $0.00 116.28%
Susquehanna International Group, LLP 20.94K Dec 31, 2025 0.22% $0.00 -0.24%
Jane Street Group LLC 13.19K Dec 31, 2025 0.14% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Simplify Propel Opportunities ETF 149.28K 1.59% ▲ 0.00% Mar 30, 2026
2 Vanguard Total Stock Mkt Idx Inv 104.97K 1.12% ▲ 0.00% Feb 28, 2026
3 Vanguard Institutional Extnd Mkt Idx Tr 31.05K 0.33% ▲ 0.00% Feb 28, 2026
4 Extended Equity Market Fund K 15.97K 0.17% ▲ 0.00% Mar 31, 2026
5 NT Ext Equity Mkt Idx Fd - L 7.57K 0.08% ▲ 206.64% Dec 31, 2025
6 Fidelity Total Market Index 4.76K 0.05% ▲ 0.00% Feb 28, 2026
7 Fidelity Series Total Market Index 3.93K 0.04% ▲ 0.00% Feb 28, 2026
8 DFA US Micro Cap I 3.77K 0.04% ▲ 0.00% Feb 28, 2026
9 Spartan Extended Market Index Pool F 3.43K 0.04% ▲ 0.00% Feb 28, 2026
10 NT Ext Eq Mkt Indx Fd DC Lending Tier 5 2.97K 0.03% ▲ 325.68% Dec 31, 2025

Financial Highlights

▼
Market Cap: $26.62M
EBITDA: $-38.30M
Book Value: $6.79
Earnings/Share: $-9.67
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -42.21%
ROE (TTM): -89.42%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $47.20M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 3.94M
Shares Float: 981.20K
% Insiders: 13.37%
% Institutions: 85.52%
Shares Short: 7.03K
Shares Short (Prior Month): 8.05K
Short Ratio: 0.37
Short % Float: 0.21%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
No revenue data found for the selected year.

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ATHA.US!